Azelaic Acid: Is Daily Long-Term Use Safe?

Azelaic acid is a naturally occurring compound widely used in dermatology for acne, rosacea and hyperpigmentation. Its record in those conditions is well documented. What people ask about here is different: whether applying it to the scalp every day, for months or years, is a reasonable thing to do — and that question has much less evidence behind it.

This article sets out what the published literature says about long-term tolerance, what the product labels say, what community members report, and where the claims made for scalp use run past the data.

The Evolution of Knowledge on the Safety of Azelaic Acid

Azelaic acid has been studied since the 1980s, almost entirely in acne, rosacea and pigmentation. Colonna (Giornale Italiano di Dermatologia e Venereologia, 1989) reported long-term clinical results with azelaic acid in acne. Fitton and Goa's pharmacological review (Drugs, 1991) described a favourable tolerability profile in which adverse effects were predominantly local and mild — burning, stinging, itching and scaling at the application site. Graupe, Cunliffe, Gollnick and Zaumseil (Cutis, 1996) published an overview, written by the manufacturer (Schering), of the European clinical trials and experimental reports on 20% azelaic acid cream, which likewise reported good tolerance in acne. In 2015 the FDA approved a 15% foam formulation for papulopustular rosacea, adding another long-term-use indication.

Two points follow from that history. The tolerability record is real, and it is a record of facial skin in acne, rosacea and pigmentation. Regulators have approved azelaic acid for those conditions, not for hair loss, and the long-term data does not carry over automatically to daily scalp application, to alcohol-based scalp vehicles, or to use alongside other scalp actives.

What Commercial Products Say About Its Daily Use

Azelaic acid appears in products aimed at androgenetic alopecia because of reports that it inhibits 5-alpha reductase, the enzyme that converts testosterone into dihydrotestosterone (DHT). That inhibition has been shown in laboratory assays rather than demonstrated in a living scalp. Manufacturers have nonetheless developed hair lotions and serums containing azelaic acid and market them as complementary or alternative options to finasteride and minoxidil.

Products discussed by community members include DS Laboratories' hair serum, which the company lists as containing azelaic acid, caffeine and biotin and describes as a daily product applied at night. Another is Lipogaine Big 3 Shampoo, which the manufacturer lists as combining azelaic acid with ketoconazole and saw palmetto — ingredients often described as reducing scalp DHT, on evidence that is largely laboratory-based rather than clinically measured. The shampoo is sold for frequent rather than necessarily daily use. These compositions and usage directions are the manufacturers' own claims; none of these products has published trial evidence behind it.

Not every azelaic acid hair product is intended for indefinite use. Some brands state that theirs should be a complement, and that any DHT reduction is likely to be smaller than with approved pharmacological treatments such as finasteride. Manufacturers also emphasise checking scalp tolerance, since irritation is more likely at higher concentrations or where several actives are layered. These labels commonly advise dermatological supervision, particularly for anyone with sensitive skin or a dry scalp.

User Experiences

Community feedback on long-term daily azelaic acid for the scalp is mixed: some report benefit, others irritation or little effect. Several users describe it as generally well tolerated, with the practical outcome depending on individual sensitivity.

One user said they applied azelaic acid daily for over a year and saw some improvement in scalp condition, particularly less inflammation and oil, but no significant regrowth. Another with sensitive skin reported mild irritation from daily use that settled when they dropped to every other day — an adjustment several members describe making.

Some question azelaic acid as a standalone treatment for hair loss, and describe using it within a regimen that already included finasteride or minoxidil on the assumption that its DHT-blocking effect is mild. Formulation comes up often: several prefer a serum or cream base, reporting that alcohol-based solutions caused dryness and irritation.

There are also reports of azelaic acid helping scalp conditions such as seborrhoeic dermatitis. Others are sceptical about long-term effect on regrowth, suggesting that a healthier scalp environment is not by itself a route to meaningful hair restoration.

Community feedback overall points to azelaic acid being tolerated by many people on daily long-term use, with the caveat that members monitor their own scalp and adjust frequency. These are self-reports, not safety data, and they say nothing about people who stopped early and did not post.

Side Effects and Their Evolution Over Time

The side effects reported with azelaic acid are local. In the first weeks of application, users commonly report redness, flaking and a mild burning or stinging sensation; product information and the acne literature describe these as usually settling as the skin adapts. This matches the adverse-effect profile in the acne and rosacea trials, where local irritation was the dominant complaint.

In people with a more reactive skin barrier, or those layering azelaic acid with other scalp actives such as ketoconazole or a topical anti-androgen, irritation can persist and frequency may need to be reduced. Persistent irritation is a reason to speak to a doctor or pharmacist rather than to push through it.

The one randomised trial of azelaic acid applied to the scalp gives a limited but real safety signal. Thanomkitti and colleagues (Siriraj Medical Journal, 2023) randomised 26 women with female pattern hair loss to 5% azelaic acid solution or 2% minoxidil solution twice daily for six months. Itching was the main adverse effect in both groups and was described as mild and tolerable. That is 26 patients over six months — it does not establish safety over years, and no trial has followed daily scalp use for longer.

No published study has measured whether topical azelaic acid on the scalp affects systemic hormone levels. Topical agents are generally absorbed poorly compared with oral drugs, and azelaic acid is not known to act systemically at the doses used on skin, but that is a reasonable expectation rather than a measured result, and it should not be presented as a demonstrated contrast with oral finasteride.

Where azelaic acid is used long-term on the scalp, the practical advice found on product labels and repeated by community members is to watch for irritation and adjust frequency, and to raise persistent side effects with a clinician.

Comparison with Other Treatments for Alopecia and DHT Reduction

Azelaic acid is often compared with other topicals used against androgenetic alopecia. Topical finasteride is a direct 5-alpha reductase inhibitor with clinical trial evidence for hair loss; azelaic acid's inhibition of the same enzyme has been shown in laboratory assays, and no study has compared the two head to head.

Minoxidil is a vasodilator that promotes hair growth and does not act on DHT. Combining minoxidil with azelaic acid is discussed, but no trial of the combination against minoxidil alone could be located, so claims that adding azelaic acid improves on minoxidil are unsupported. The only direct comparison published is Thanomkitti 2023, in which 5% azelaic acid and 2% minoxidil produced similar results in 26 women over six months — a study too small to establish equivalence, and one without a placebo arm.

Ketoconazole, an antifungal, is used off-label in hair loss on the basis of an anti-androgenic effect. The claim that it reduces scalp DHT rests on laboratory and inferential evidence rather than on clinical measurement of scalp DHT, and it is not an approved hair loss treatment.

On safety, azelaic acid's adverse effects in the dermatological literature are local rather than systemic, which is the main reason it is discussed as a gentler option than oral finasteride. How much it reduces DHT in a living scalp is unresolved, and the published literature does not support presenting it as an alternative to approved treatments. Topical retinoids such as tretinoin and adapalene, by comparison, can cause marked irritation and increased sun sensitivity with prolonged use.

Conclusion

Azelaic acid has a long tolerability record in acne, rosacea and pigmentation, where the reported adverse effects are local and usually mild, and where 15% and 20% formulations are approved for extended use. That record is about facial skin, and it is the strongest thing that can be said here.

For daily long-term use on the scalp, the evidence is one randomised trial in 26 women over six months, in which mild itching was the main side effect. There is no long-term scalp safety data, no measurement of systemic effects from scalp application, and no established efficacy for hair loss. Individual tolerance varies, and irritation is the effect most often reported.

Talk to a doctor, dermatologist or pharmacist before starting azelaic acid on the scalp, before combining it with other scalp treatments, and if irritation persists — and note that 15% and 20% azelaic acid are prescription medicines in many countries, and that any decision to use one off-label on the scalp is a decision to make with a clinician rather than alone.

References

Colonna, S. M. (1989). [Validity of azelaic acid in the therapy of acne. Long-term clinical results]. Giornale Italiano di Dermatologia e Venereologia, 124(10), 479–484. https://pubmed.ncbi.nlm.nih.gov/2534553/

Fitton, A., & Goa, K. L. (1991). Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs, 41(5), 780–798. https://pubmed.ncbi.nlm.nih.gov/1712709/

Graupe, K., Cunliffe, W. J., Gollnick, H. P., & Zaumseil, R. P. (1996). Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis, 57(1 Suppl), 20–35. https://pubmed.ncbi.nlm.nih.gov/8654128/

Thanomkitti, K., Pruksaeakanan, C., Subchookul, C., Charoenpipatsin, N., Triwongwaranat, D., Varothai, S., Thuangtong, R., & Chumnumrat, T. (2023). Efficacy and Safety of Topical 5% Azelaic Acid Solution Versus 2% Minoxidil Solution in the Treatment of Female Pattern Hair Loss. Siriraj Medical Journal, 75(12), 887–893. https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/266001

Brooks, M. (2015). FDA OKs Azelaic Acid (Finacea) for Papulopustular Rosacea. Medscape. https://www.medscape.com/viewarticle/848933